Ola Kalisz
@olakalisz.bsky.social
PhD student at FLAIR, University of Oxford
@flair-ox.bsky.social, @universityofoxford.bsky.social
Previously a Senior AI Research Scientist at Exscientia
@flair-ox.bsky.social, @universityofoxford.bsky.social
Previously a Senior AI Research Scientist at Exscientia
Antiviral therapy design is myopic 🦠🙈 optimised only for the current strain. That's why you need a different Flu vaccine every year!
Our #ICML2025 paper ADIOS proposes "shaper therapies" that steer viral evolution in our favour & remain effective. Work done @flair-ox.bsky.social
🧵👇
Our #ICML2025 paper ADIOS proposes "shaper therapies" that steer viral evolution in our favour & remain effective. Work done @flair-ox.bsky.social
🧵👇
July 2, 2025 at 1:11 PM
Antiviral therapy design is myopic 🦠🙈 optimised only for the current strain. That's why you need a different Flu vaccine every year!
Our #ICML2025 paper ADIOS proposes "shaper therapies" that steer viral evolution in our favour & remain effective. Work done @flair-ox.bsky.social
🧵👇
Our #ICML2025 paper ADIOS proposes "shaper therapies" that steer viral evolution in our favour & remain effective. Work done @flair-ox.bsky.social
🧵👇